<DOC>
	<DOCNO>NCT02759822</DOCNO>
	<brief_summary>This prospective observational cohort study haploidentical transplantation post-transplant cyclophosphamide acute leukemia use reduce intensity condition acute myeloid leukemia ( AML ) myeloablative condition acute lymphoblastic leukemia ( ALL ) .</brief_summary>
	<brief_title>Haploidentical Hematopoietic Stem Cell Transplantation Acute Leukemias</brief_title>
	<detailed_description>Hematopoietic stem cell transplantation ( HSCT ) effective treatment acute myeloid leukemia ( AML ) acute lymphoblastic leukemia ( ALL ) , low rate relapse . Fertility rate Brazil fall , 25 % people bear today match sibling donor . On hand , currently donor non-related 50 % patient enrol Brazilian Receptor Registry ( REREME ) . Consequently , least 35 % patient wo n't match donor . The haploidentical transplantation define partially match hematopoietic cell transplantation , use partially match family donor ( parent , sibling child ) . Haploidentical transplantation activity grow worldwide , result comparable matched unrelated donor . The objective study test feasibility haploidentical transplantation post transplant cyclophosphamide acute leukemia Brazil .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Acute lymphoblastic leukemia acute myeloid leukemia Severe comorbidities Second transplant</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Haploidentical Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Partially Matched Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Post-transplant Cyclophosphamide</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>